Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Thomas Ming Swi Chang. (2019) ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 997-1013.
Read now
Read now
Chen Guo & Thomas Ming Swi Chang. (2018) Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion. Artificial Cells, Nanomedicine, and Biotechnology 46:7, pages 1349-1363.
Read now
Read now
Anna Wrobeln, Klaus D. Schlüter, Jürgen Linders, Manfred Zähres, Christian Mayer, Michael Kirsch & Katja B. Ferenz. (2017) Functionality of albumin-derived perfluorocarbon-based artificial oxygen carriers in the Langendorff-heart
. Artificial Cells, Nanomedicine, and Biotechnology 45:4, pages 723-730.
Read now
Read now
Y. Z. Bian, C. Guo & T. M. S. Chang. (2016) Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at −80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C. Artificial Cells, Nanomedicine, and Biotechnology 44:1, pages 41-47.
Read now
Read now
Articles from other publishers (7)
Rongrong Liu, Wanjun Wang, Yaoxi Wang, Lili Zhang & Gang Chen. (2023) The Preliminary Study on Preparation Technology of PolyHb-SOD-CATCA
- The Effects of Different Extractants. Current Pharmaceutical Biotechnology 24:15, pages 1928-1937.
Crossref
Crossref
Wentao Jiang, Ziyu Wu, Zheng Gao, Mimi Wan, Min Zhou, Chun Mao & Jian Shen. (2022) Artificial Cells: Past, Present and Future. ACS Nano 16:10, pages 15705-15733.
Crossref
Crossref
Clara Coll-Satue, Shahana Bishnoi, Jiantao Chen & Leticia Hosta-Rigau. (2021) Stepping stones to the future of haemoglobin-based blood products: clinical, preclinical and innovative examples. Biomaterials Science 9:4, pages 1135-1152.
Crossref
Crossref
Hans Bäumler. (2020) Künstliche Sauerstofftransporter können mehr als Sauerstoff liefern. Transfusionsmedizin - Immunhämatologie · Hämotherapie · Transplantationsimmunologie · Zelltherapie 10:04, pages 199-207.
Crossref
Crossref
Anna Wrobeln, Johannes Jägers, Theresa Quinting, Timm Schreiber, Michael Kirsch, Joachim Fandrey & Katja B. Ferenz. (2020) Albumin-derived perfluorocarbon-based artificial oxygen carriers can avoid hypoxic tissue damage in massive hemodilution. Scientific Reports 10:1.
Crossref
Crossref
Fan Zhang, Ze-Bing Zheng, Zhao-Qiong Zhu, De-Xing Liu & Jin Liu. (2019) Application of Perioperative Transfusion Trigger Score in Patients Undergoing Surgical Treatment of Malignant Tumor. Indian Journal of Hematology and Blood Transfusion 36:1, pages 156-163.
Crossref
Crossref
Jan Simoni. (2017) Artificial Oxygen Carriers: Exactly How Close Are We to an Ultimate Product?. Artificial Organs 41:4, pages 316-318.
Crossref
Crossref